Glenn Dubin - Net Worth and Insider Trading

Glenn Dubin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glenn Dubin owns 5 companies in total, including Ambassadors International Inc (AMIEQ) , Golden Minerals Co (AUMN) , and Enzon Pharmaceuticals Inc (ENZN) among others .

Click here to see the complete history of Glenn Dubin’s form 4 insider trades.

Insider Ownership Summary of Glenn Dubin

Ticker	Comapny	Transaction Date	Type of Owner
AMIEQ	Ambassadors International Inc	2011-03-31	10 percent owner
AUMN	Golden Minerals Co	2009-03-24	10 percent owner
ENZN	Enzon Pharmaceuticals Inc	2007-01-26	10 percent owner
		2004-10-29	10 percent owner
		2021-03-12	director

Glenn Dubin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Glenn Dubin Ownership Network

Ownership Network List of Glenn Dubin

No Data

Ownership Network Relation of Glenn Dubin

Glenn Dubin Owned Company Details

What does Ambassadors International Inc do?

Who are the key executives at Ambassadors International Inc?

Glenn Dubin is the 10 percent owner of Ambassadors International Inc. Other key executives at Ambassadors International Inc include other: Former 10% Owner WHIPPOORWILL ASSOCIATES, INC. , other: Former 10% Owner Shelley F Greenhaus , and other: Former 10% Owner Steven K. Gendal .

Ambassadors International Inc (AMIEQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ambassadors International Inc (AMIEQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ambassadors International Inc (AMIEQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ambassadors International Inc (AMIEQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ambassadors International Inc Insider Transactions

No Available Data

What does Golden Minerals Co do?

Who are the key executives at Golden Minerals Co?

Glenn Dubin is the 10 percent owner of Golden Minerals Co. Other key executives at Golden Minerals Co include Executive Vice President Pablo Castanos , Chief Operating Officer John Galassini , and Senior VP and CFO Julie Weedman .

Golden Minerals Co (AUMN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Golden Minerals Co (AUMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Golden Minerals Co (AUMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Golden Minerals Co (AUMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Golden Minerals Co Insider Transactions

No Available Data

What does Enzon Pharmaceuticals Inc do?

Who are the key executives at Enzon Pharmaceuticals Inc?

Glenn Dubin is the 10 percent owner of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .

Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary

Over the past 18 months, Glenn Dubin made no insider transaction in Enzon Pharmaceuticals Inc (ENZN). Other recent insider transactions involving Enzon Pharmaceuticals Inc (ENZN) include a net purchase of 99,550 shares made by Randolph C Read ,

In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 99,550 shares were bought by its insiders, resulting in a net purchase of 99,550 shares.

Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enzon Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Glenn Dubin is the 10 percent owner of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Glenn Dubin made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

What does C4 Therapeutics Inc do?

Who are the key executives at C4 Therapeutics Inc?

Glenn Dubin is the director of C4 Therapeutics Inc. Other key executives at C4 Therapeutics Inc include Chief Financial Officer Kendra Adams , Chief Accounting Officer Mark Mossler , and Chief Medical Officer Leonard Reyno .

C4 Therapeutics Inc (CCCC) Insider Trades Summary

Over the past 18 months, Glenn Dubin made no insider transaction in C4 Therapeutics Inc (CCCC). Other recent insider transactions involving C4 Therapeutics Inc (CCCC) include a net purchase of 5,667 shares made by Utpal Koppikar ,

In summary, during the past 3 months, insiders sold 0 shares of C4 Therapeutics Inc (CCCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of C4 Therapeutics Inc (CCCC) were sold and 5,667 shares were bought by its insiders, resulting in a net purchase of 5,667 shares.

C4 Therapeutics Inc (CCCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

C4 Therapeutics Inc Insider Transactions

No Available Data

Glenn Dubin Mailing Address

Above is the net worth, insider trading, and ownership report for Glenn Dubin. You might contact Glenn Dubin via mailing address: C/o Highbridge Capital Management, Llc, 40 West 57th Street, 32nd Floor, New York Ny 10019.

Discussions on Glenn Dubin

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.